Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Barrett Esophagus × Spectrum Analysis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Neoplasm Metastasis 2 Lung Neoplasms 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Neoplasms 1 Lymphatic Metastasis 1 Carcinoma, Non-Small-Cell Lung 1 Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 12 Endoscopy, Digestive System 8 Endoscopic Mucosal Resection 8 Gastroscopy 5 Biopsy 5 Specimen Handling 4 Omeprazole 4 Radiofrequency Ablation 3 Esomeprazole 3 Breath Tests 3 Proton Pump Inhibitors 2 Photochemotherapy 2 Narrow Band Imaging 2 Microscopy, Confocal 2 Endoscopes 2 Diagnostic Imaging 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 omeprazole, sodium bicarbonate drug combination 1 gluconic acid 1 chlorhexidine gluconate 1 candesartan cilexetil 1 candesartan 1 YF 476 1 Tomography, Optical Coherence 1 Tamoxifen 1 Surveys and Questionnaires 1 Standard of Care 1 Spectrum Analysis 1 Sampling Studies 1 Risk Assessment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05745857 2023-02-27

SLURP

University Medical Center Groningen

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡